These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21843546)

  • 1. Chronic agomelatine and fluoxetine induce antidepressant-like effects in H/Rouen mice, a genetic mouse model of depression.
    El Yacoubi M; Dubois M; Gabriel C; Mocaër E; Vaugeois JM
    Pharmacol Biochem Behav; 2011 Dec; 100(2):284-8. PubMed ID: 21843546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice.
    Païzanis E; Renoir T; Lelievre V; Saurini F; Melfort M; Gabriel C; Barden N; Mocaër E; Hamon M; Lanfumey L
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):759-74. PubMed ID: 19775499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.
    Rainer Q; Xia L; Guilloux JP; Gabriel C; Mocaër E; Hen R; Enhamre E; Gardier AM; David DJ
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):321-35. PubMed ID: 21473810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.
    Bourin M; Mocaër E; Porsolt R
    J Psychiatry Neurosci; 2004 Mar; 29(2):126-33. PubMed ID: 15069466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association between helpless trait and depression-related phenotypes: evidence from crossbreeding studies with H/Rouen and NH/Rouen mice.
    El Yacoubi M; Popa D; Martin B; Zimmer L; Hamon M; Adrien J; Vaugeois JM
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):363-74. PubMed ID: 21557882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of agomelatine in the chronic mild stress model of depression in the rat.
    Papp M; Gruca P; Boyer PA; Mocaër E
    Neuropsychopharmacology; 2003 Apr; 28(4):694-703. PubMed ID: 12655314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The H/Rouen mouse model displays depression-like and anxiety-like behaviors.
    El Yacoubi M; Rappeneau V; Champion E; Malleret G; Vaugeois JM
    Behav Brain Res; 2013 Nov; 256():43-50. PubMed ID: 23933146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behaviour of a genetic mouse model of depression in the learned helplessness paradigm.
    Bougarel L; Guitton J; Zimmer L; Vaugeois JM; El Yacoubi M
    Psychopharmacology (Berl); 2011 Jun; 215(3):595-605. PubMed ID: 21340472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
    Schmelting B; Corbach-Söhle S; Kohlhause S; Schlumbohm C; Flügge G; Fuchs E
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):437-47. PubMed ID: 23978391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus.
    Lu Y; Ho CS; McIntyre RS; Wang W; Ho RC
    Life Sci; 2018 Oct; 210():177-184. PubMed ID: 30193943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine and tianeptine antidepressant activity in mice behavioral despair tests is enhanced by DMPX, a selective adenosine A
    Szopa A; Bogatko K; Serefko A; Wyska E; Wośko S; Świąder K; Doboszewska U; Wlaź A; Wróbel A; Wlaź P; Dudka J; Poleszak E
    Pharmacol Rep; 2019 Aug; 71(4):676-681. PubMed ID: 31200233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.
    Ladurelle N; Gabriel C; Viggiano A; Mocaër E; Baulieu EE; Bianchi M
    Psychopharmacology (Berl); 2012 Jun; 221(3):493-509. PubMed ID: 22160164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain.
    Hanoun N; Mocaër E; Boyer PA; Hamon M; Lanfumey L
    Neuropharmacology; 2004 Sep; 47(4):515-26. PubMed ID: 15380370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors.
    Millan MJ; Marin P; Kamal M; Jockers R; Chanrion B; Labasque M; Bockaert J; Mannoury la Cour C
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):768-83. PubMed ID: 20946699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway.
    Thomas J; Khanam R; Vohora D
    Neurochem Int; 2016 Oct; 99():103-109. PubMed ID: 27311540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
    Norman TR; Cranston I; Irons JA; Gabriel C; Dekeyne A; Millan MJ; Mocaër E
    Eur J Pharmacol; 2012 Jan; 674(1):27-32. PubMed ID: 22040921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antidepressant activity of vanillin in mice.
    Shoeb A; Chowta M; Pallempati G; Rai A; Singh A
    Indian J Pharmacol; 2013; 45(2):141-4. PubMed ID: 23716889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
    Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
    Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of caffeine after its chronic administration modifies the antidepressant-like activity of atypical antidepressants in mice. Changes in cortical expression of Comt, Slc6a15 and Adora1 genes.
    Szopa A; Poleszak E; Doboszewska U; Herbet M; Świąder K; Wyska E; Serefko A; Wlaź A; Korga A; Ostrowska M; Juś P; Jedynak S; Dudka J; Wlaź P
    Psychopharmacology (Berl); 2018 Aug; 235(8):2423-2434. PubMed ID: 29882086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression.
    Stein DJ; Picarel-Blanchot F; Kennedy SH
    Hum Psychopharmacol; 2013 Mar; 28(2):151-9. PubMed ID: 23532747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.